부산대학교 도서관

This article provides an overview of a pancreatic cancer screening program, highlighting the importance of early detection for improving survival rates. While routine screening is not recommended for the general population, certain high-risk groups may benefit from screening. The article outlines the structure of a screening program, including patient identification, screening approaches, surveillance methods, and the use of biomarkers. The goal is to provide a blueprint for similar screening initiatives. The article also discusses the anticipated yield for detecting high-risk lesions and addresses considerations such as financial burden and partial inclusion criteria. The future of pancreatic cancer screening looks promising with advancements in biomarkers, radiomics, and artificial intelligence. The conclusion emphasizes the need for a standardized, multidisciplinary, and inclusive screening program. [Extracted from the article]